Your browser doesn't support javascript.
loading
Lung Ultrasound in the Evaluation of Lung Disease Severity in Children with Clinically Stable Cystic Fibrosis: A Prospective Cross-Sectional Study.
Jaworska, Joanna; Buda, Natalia; Kwasniewicz, Piotr; Komorowska-Piotrowska, Anna; Sands, Dorota.
Afiliação
  • Jaworska J; Cystic Fibrosis Department, Institute of Mother and Child, 01-211 Warsaw, Poland.
  • Buda N; Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdansk, 80-214 Gdansk, Poland.
  • Kwasniewicz P; Department of Diagnostic Imaging, Institute of Mother and Child, 01-211 Warsaw, Poland.
  • Komorowska-Piotrowska A; Specialist Centre for Diagnostics and Therapy of a Small Child BALUMED, 02-972 Warsaw, Poland.
  • Sands D; Cystic Fibrosis Department, Institute of Mother and Child, 01-211 Warsaw, Poland.
J Clin Med ; 12(9)2023 Apr 24.
Article em En | MEDLINE | ID: mdl-37176526
ABSTRACT
With the increasing longevity of cystic fibrosis (CF), there is a growing need to minimise exposure to ionising radiation in patients who undergo regular imaging tests while monitoring the course of the lung disease. This study aimed to define the role of lung ultrasounds (LUS) in the evaluation of lung disease severity in children with clinically stable CF. LUS was performed on 131 patients aged 5 weeks to 18 years (study group) and in 32 healthy children of an equivalent age range (control group). Additionally, an interobserver study was performed on 38 patients from the study group. In CF patients, the following ultrasound signs were identified I-lines; Z-lines; single, numerous and confluent B-lines; Am-lines; small and major consolidations; pleural line abnormalities and small amounts of pleural fluid. The obtained results were evaluated against an original ultrasound score. LUS results were correlated with the results of chest X-ray (CXR) [very high], pulmonary function tests (PFTs) [high] and microbiological status [significant]. The interobserver study showed very good agreement between investigators. We conclude that LUS is a useful test in the evaluation of CF lung disease severity compared to routinely used methods. With appropriate standardisation, LUS is highly reproducible.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article